Key result
Lead V3 P-wave amplitude identifies pediatric ASD with ~0.88 AUROC, outperforming conventional ECG findings.
Why the study?
Atrial septal defects are often asymptomatic in childhood and difficult to detect by conventional ECG screening relying mainly on QRS abnormalities, limiting early diagnosis.
Does baseline-corrected P-wave amplitude accurately identify pediatric atrial septal defects compared to conventional ECG findings?
Observational (n=139)
Does baseline-corrected P-wave amplitude accurately identify pediatric atrial septal defects compared to conventional ECG findings?
Effect estimate: AUROC 0.883
Baseline-corrected P-wave amplitude in lead V3 accurately discriminates pediatric patients with hemodynamically significant atrial septal defects from healthy controls.
Baseline-corrected P-wave analysis may aid ASD detection on ECG; leaves open prospective validation before screening use.
BACKGROUND: Atrial septal defects (ASD) are often asymptomatic during childhood, resulting in a delayed diagnosis. Electrocardiography (ECG) screening is known to have a limited ability to detect ASD, relying mainly on QRS abnormalities, such as incomplete right bundle branch block (IRBBB). In contrast, P waves have been underused because they are small, often on a trended baseline, and thus difficult to quantify accurately. This observational study examined the utility of baseline-corrected P-wave amplitude in the identification of ASD. METHODS: We analyzed digital ECG data from 45 secundum ASD patients 4-9 years old and 94 matched controls without structural heart defects. Using a semi-automated algorithm, we precisely measured the P-wave amplitude following rigorous baseline correction. We conducted a receiver operating characteristic (ROC) curve analysis to differentiate ASD patients from controls. RESULTS: The overall performance of the P-wave amplitude in lead V3 was high, with an area under the ROC curve (AUROC) of 0.883. When the analysis was limited to patients with defect sizes of ≥5 mm, the V3 amplitude had an excellent AUROC (0.954) with 83.3% sensitivity and 95.7% specificity, outperforming conventional ECG findings, including IRBBB. This significance was supported by a good correlation between the V3 amplitude and the right atrial size quantified by echocardiography. CONCLUSIONS: The present study demonstrates the potential utility of accurately measured P-wave amplitude for the detection of hemodynamically significant pediatric ASD. Further investigations, including external validation in diverse clinical settings and the development of a fully automated analytic algorithm, are required before clinical implementation.
No takes yet. Share an insight, caveat, or question.
Kumamoto et al. (2026) conducted an observational in pediatric atrial septal defects (n=139). Baseline-corrected P-wave amplitude vs. Controls without structural heart defects was evaluated on Differentiation of ASD patients from controls (AUROC 0.883). Baseline-corrected P-wave amplitude in lead V3 accurately identified pediatric atrial septal defects, achieving an AUROC of 0.883 overall and 0.954 for defects ≥5 mm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: